I only have one question.
I apologize for my absence, but I was speaking to the very important Bill C-42, on the proposed quarantine act put forward by the Ministry of Health. I knew you would want an articulate speech on that.
I gather from some earlier discussion that what you hear about drug costs usually comes from the pharmaceutical plans, such as the insurance plans or from the provincial government plans or agencies. Of course the questions I get are obviously from individual constituents.
Within the government, where is that responsibility and what is happening? If we're hearing from provincial plans that it's too expensive, I'm hearing from constituents that it's too expensive, and I can see some people here in the audience today who represent people who can't afford some of the medications they're prescribed, how is it addressed, knowing that you have two groups of people? Where does it land inside government? Who picks it up and says we should do something with this? What is it?